Related Experiment Video
Updated: Jun 5, 2026
16:07
Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Tumor necrosis factor receptor cross-talk.
Petrus J W Naudé1, Johan A den Boer, Paul G M Luiten
1Department of Molecular Neurobiology, University of Groningen, The Netherlands.
The FEBS Journal
|January 15, 2011
Summary
Tumor necrosis factor receptor 1 (TNFR1) and TNFR2 signaling pathways are complex. This review explores their cross-talk and kinetics, crucial for maintaining cell survival and apoptosis balance.
Area of Science:
- Immunology
- Cellular Biology
- Molecular Signaling
Background:
- Extensive research has elucidated tumor necrosis factor receptor 1 (TNFR1) signaling pathways.
- Cellular signaling upon activation of tumor necrosis factor receptor 2 (TNFR2) remains less understood.
- Emerging data suggest cross-talk and mutual influence between TNFR1 and TNFR2 signaling.
Purpose of the Study:
- To review known signaling factors involved in TNFR1 and TNFR2 receptor cross-talk.
- To elucidate the kinetics of signaling pathways initiated by TNFR1 and TNFR2 stimulation.
- To understand how receptor cross-talk influences the balance between cell survival and apoptosis.
Main Methods:
- Literature review of published research on TNFR1 and TNFR2 signaling.
- Analysis of studies investigating the interplay between TNFR1 and TNFR2 pathways.
- Examination of data on signaling kinetics and their impact on cellular fate.
Main Results:
- TNFR1 and TNFR2 can function independently but also influence each other through cross-talk.
- The complexity of this cross-talk is modulated by distinct signaling kinetics of TNFR1 and TNFR2.
- A balance between cell survival and apoptosis is maintained through intricate receptor cross-talk.
Conclusions:
- Understanding TNFR1-TNFR2 cross-talk is essential for comprehending cellular responses to TNF signaling.
- Signaling kinetics play a critical role in mediating the functional outcomes of TNFR1 and TNFR2 activation.
- Further research into these pathways could reveal therapeutic targets for diseases involving TNF signaling.
Related Concept Videos
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...